Concepedia

Author

Vincent Doré

Austin HealthORCID

Also Known As

C. Elizabeth Shaaban, D. Vincent, David Hanson, Doré, V., Doré, Vincent, Jo Robertson, Steven Collins, The AIBL Research Group, V Dore, V. Dore

425

Publications

9.1K

Citations

43

H-Index

84

Concepts

All Affiliations

Austin HealthThe University of MelbourneFlorey Institute of Neuroscience and Mental HealthAustralian e-Health Research CentreCSIRO Health and Biosecurity
VD

About

Vincent Doré is an author at Austin Health specializing in neuroscience, medicine, and alzheimer's disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

16

2.6K

2

Health Sciences

7

7

498

3

Engineering

5

5

348

4

Social Sciences

2

2

83

5

Natural Sciences

1

1

152

Vincent Doré

×

94

Publications

7.6K

Citations

41

H-Index

YearCitations

High performance plasma amyloid-β biomarkers for Alzheimer’s disease

Akinori Nakamura, Naoki Kaneko, Victor L. Villemagne,

Nature

2018

1.6K

Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline

Rik Ossenkoppele, Alexa Pichet Binette, Colin Groot,

Nature Medicine

2022

446

Multisite study of the relationships between <i>antemortem</i> [<sup>11</sup>C]PIB‐PET Centiloid values and <i>postmortem</i> measures of Alzheimer's disease neuropathology

Renaud La Joie, Nagehan Ayakta, William W. Seeley,

Alzheimer s & Dementia

2018

307

Sex, amyloid, and <i>APOE</i> ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well‐characterized cohorts

Rachel F. Buckley, Elizabeth C. Mormino, Rebecca E. Amariglio,

Alzheimer s & Dementia

2018

264

Plasma Aβ42/40 ratio, p‐tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross‐sectional and longitudinal study in the AIBL cohort

Pratishtha Chatterjee, Steve Pedrini, James D. Doecke,

Alzheimer s & Dementia

2022

260

Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's disease

Pratishtha Chatterjee, Steve Pedrini, Nicholas J. Ashton,

Alzheimer s & Dementia

2021

219

Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study

Samantha C. Burnham, Pierrick Bourgeat, Vincent Doré,

The Lancet Neurology

2016

216

High performance plasma amyloid-beta biomarkers for Alzheimer's disease

Akinori Nakamura, Naoki Kaneko, Victor L. Villemagne,

Nature

2018

204

Cross-sectional and Longitudinal Analysis of the Relationship Between Aβ Deposition, Cortical Thickness, and Memory in Cognitively Unimpaired Individuals and in Alzheimer Disease

Vincent Doré, Victor L. Villemagne, Pierrick Bourgeat,

JAMA Neurology

2013

185

In vivo evaluation of a novel tau imaging tracer for Alzheimer’s disease

Victor L. Villemagne, Shozo Furumoto, Michelle T. Fodero‐Tavoletti,

European Journal of Nuclear Medicine and Molecular Imaging

2014

166

Page 1